Treatment of cardiac rhabdomyomas with mTOR inhibitors in children with tuberous sclerosis complex—a systematic review

M Sugalska, A Tomik, S Jóźwiak, B Werner - International Journal of …, 2021 - mdpi.com
Background: Cardiac rhabdomyomas (CRs) are the earliest sign of tuberous sclerosis
complex (TSC). Most of them spontaneously regress after birth. However, multiple and/or …

[HTML][HTML] Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus

R Previtali, G Prontera, E Alfei, L Nespoli… - Pharmacological …, 2023 - Elsevier
Tuberous sclerosis complex is an autosomal dominant disease characterised by abnormal
cell proliferation and differentiation that affects multiple organs and can lead to the growth of …

Monitoring and managing patients with tuberous sclerosis complex: current state of knowledge

I Gomes, J Jesus Ribeiro, F Palavra - Journal of Multidisciplinary …, 2022 - Taylor & Francis
Tuberous sclerosis complex (TSC) is a rare genetic disease of autosomal dominant
transmission that, in most cases, results from the presence of pathogenic variants of the …

Cardiac tumors

CJT Karigyo, BMS Pessoa, SP Nicacio… - Brazilian Journal of …, 2024 - SciELO Brasil
Cardiac tumors are rare and encompass a variety of presentations. Clinica symptoms are
usually nonspecific, but they can present as obstructive, embolic, or constitutional symptoms …

Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus

D Hurtado-Sierra, JX Ramos Garzón, LZ Rojas… - Frontiers in …, 2023 - frontiersin.org
Cardiac rhabdomyoma (CRHM) is the principal cardiac tumor in children and is most often
associated with tuberous sclerosis complex (TSC). Mutations in the TSC1 and TSC2 genes …

Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas

MP Silva‐Sánchez… - American Journal of …, 2021 - Wiley Online Library
Intracardiac rhabdomyoma is the most common primary cardiac tumor in children. Most
cases are associated with tuberous sclerosis complex (TSC). Most of them are asymptomatic …

Cardiac masses

RS Beroukhim, T Geva, EP Walsh, M Nathan - Nadas' Pediatric Cardiology, 2025 - Elsevier
Cardiac masses are abnormal growths of normal or abnormal tissue found within the heart
or pericardium, and can be categorized as either tumors or non-neoplastic masses. Cardiac …

Exploring Cardiovascular Involvement in Tuberous Sclerosis: Insights for Pediatric Clinicians

C Lazea, I Țaranu, SD Bolboacă - Children, 2024 - mdpi.com
Tuberous sclerosis is a rare genetic disorder involving mainly the nervous and
cardiovascular systems. The early recognition of the cardiovascular manifestations by the …

Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus

J Concha, E Sangüesa, JL Peña, MP Ribate… - …, 2023 - Taylor & Francis
Aim: Tuberous sclerosis complex (TSC) is a rare disease that produces multisystemic
disorders. Everolimus (EVR) is the only immunosuppressive drug approved to control the …

[HTML][HTML] KaRhab: an international online registry for cardiac rhabdomyomas

VM Herrmann, M Arelin, CG Bergner… - Orphanet Journal of …, 2025 - pmc.ncbi.nlm.nih.gov
Background Cardiac rhabdomyoma (RHM) is considered one of the most frequent benign
heart tumors in children. However, encounters with cardiac RHM in clinical practice remain …